Syntax Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$226K Sell
22,930
-1,669
-7% -$17.4K 0.2% 145
2023
Q2
$245K Buy
24,599
+617
+3% +$5.89K 0.2% 129
2023
Q1
$231K Buy
23,982
+1,541
+7% +$17.1K 0.17% 184
2022
Q4
$250K Sell
22,441
-3,561
-14% -$37.2K 0.21% 125
2022
Q3
$222K Buy
26,002
+4,545
+21% +$44.7K 0.19% 161
2022
Q2
$225K Sell
21,457
-1,451
-6% -$15.9K 0.19% 164
2022
Q1
$249K Buy
22,908
+2,444
+12% +$32.2K 0.21% 141
2021
Q4
$277K Buy
+20,464
New +$273K 0.2% 136

Other funds holding VTRS

Syntax Advisors's VTRS Position: Q3 2023 in Review

Syntax Advisors reduced its Viatris (VTRS) stake by 6.8% in Q3 2023, selling an estimated $17.4K and leaving 22,930 shares worth $226K. The position accounts for 0.2% of the portfolio, ranked #145.

Syntax Advisors first reported a position in VTRS in Q4 2021 and has held it in 8 quarters since. The position peaked at $277K in Q4 2021. 960 funds tracked by Wall St. Rank hold VTRS as of Q3 2023.

  • Syntax Advisors held 22,930 shares of Viatris worth $226K as of Q3 2023.
  • Syntax Advisors sold 1,669 Viatris shares in Q3 2023, an estimated $17.4K.
  • Viatris made up 0.2% of Syntax Advisors's portfolio in Q3 2023, its #145 holding.
  • Syntax Advisors first reported a position in Viatris in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Viatris position peaked at $277K in Q4 2021.
  • 960 funds tracked by Wall St. Rank held Viatris as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.